Risky reversal There is a possible Doji candle on a key level in and oversold zone via SRSI and CCI. Very risky because of the previous break of the trend line and parallel channel, but something to watch.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.94 USD
−222.61 M USD
747.72 M USD
64.95 M
About Tandem Diabetes Care, Inc.
Sector
Industry
CEO
John F. Sheridan
Website
Headquarters
San Diego
Founded
2006
FIGI
BBG0019V9M65
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
TANDEM DIABETES CARE, INC. - [TNDM]Price Action
Recent Trend: The stock has been recovering from a downtrend that occurred in June and July, and it appears to be in the midst of an uptrend since early August, with a recent push higher.
Current Price: The last closing price is $45.57, which represents a 2.87% increase.
Bolling
TNDM 'possible' double bottom and positive MACD indicator Thank you for your time and feedback.
TNDM has appeared to have formed a 'possible' double bottom, and if it breaches the neckline the price may continue to rise higher, also please be so kind to notice the positive readings on the MACD indicator.
Analysis taken on daily time frame.
Have a nice da
Will TNDM reach the price level it deserves?1) I drew Resistance Line on RSI indicator and it has been broken this month clearly. Also RSI has 2 moving averages and they crossed each other. Purple(40.29) one is more than Green(35.77) one.
2) I drew Resistance and Support Lines on Momentum indicator. Resistance line has been broken. Security h
TNDM LongMaking a pullback pattern near prior pivot, normally is a very bullish setup. It still has to cross that trend line to trigger the entry
QuantProgram seems effective for longer than 5minutes chartThe script developed by QuantProgram seems effective..
TNDM in extreme consolidation faze ➕last time it was here we saw about 6 months of consolidation, so better to wait for clear trigger break, and also shares over options due to wide spread on option chains.
long trigger is 77.60 / short trigger 47.78
TNDM looks bearishAfter a significant drop in the past 5 years, the price has raised significantly, and it seems to be a good short trade.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
TNDM5680851
Tandem Diabetes Care, Inc. 1.5% 01-MAY-2025Yield to maturity
3.60%
Maturity date
May 1, 2025
Explore more bonds
Frequently Asked Questions
The current price of TNDM is 30.60 USD — it has decreased by −8.16% in the past 24 hours. Watch Tandem Diabetes Care, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tandem Diabetes Care, Inc. stocks are traded under the ticker TNDM.
TNDM stock has fallen by −3.44% compared to the previous week, the month change is a −22.57% fall, over the last year Tandem Diabetes Care, Inc. has showed a 97.16% increase.
We've gathered analysts' opinions on Tandem Diabetes Care, Inc. future price: according to them, TNDM price has a max estimate of 75.00 USD and a min estimate of 18.00 USD. Watch TNDM chart and read a more detailed Tandem Diabetes Care, Inc. stock forecast: see what analysts think of Tandem Diabetes Care, Inc. and suggest that you do with its stocks.
TNDM reached its all-time high on Jan 14, 2014 with the price of 302.50 USD, and its all-time low was 2.14 USD and was reached on Feb 9, 2018. View more price dynamics on TNDM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TNDM stock is 13.61% volatile and has beta coefficient of 1.83. Track Tandem Diabetes Care, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tandem Diabetes Care, Inc. there?
Today Tandem Diabetes Care, Inc. has the market capitalization of 2.01 B, it has increased by 1.89% over the last week.
Yes, you can track Tandem Diabetes Care, Inc. financials in yearly and quarterly reports right on TradingView.
Tandem Diabetes Care, Inc. is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
TNDM earnings for the last quarter are −0.35 USD per share, whereas the estimation was −0.41 USD resulting in a 14.06% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Tandem Diabetes Care, Inc. earnings.
Tandem Diabetes Care, Inc. revenue for the last quarter amounts to 242.93 M USD, despite the estimated figure of 224.14 M USD. In the next quarter, revenue is expected to reach 249.81 M USD.
TNDM net income for the last quarter is −23.25 M USD, while the quarter before that showed −30.81 M USD of net income which accounts for 24.54% change. Track more Tandem Diabetes Care, Inc. financial stats to get the full picture.
No, TNDM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 2.40 K employees. See our rating of the largest employees — is Tandem Diabetes Care, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tandem Diabetes Care, Inc. EBITDA is −117.21 M USD, and current EBITDA margin is −18.56%. See more stats in Tandem Diabetes Care, Inc. financial statements.
Like other stocks, TNDM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tandem Diabetes Care, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tandem Diabetes Care, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tandem Diabetes Care, Inc. stock shows the sell signal. See more of Tandem Diabetes Care, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.